Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
peiyuan mingmu wan
- Development stage
- Unknown
- Lead developer
- Eye Hospital, China Academy of Chinese Medical Sciences
- Administration
- Oral
01
Overview
Peiyuan Mingmu Wan is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Eye Hospital of the China Academy of Chinese Medical Sciences. It is primarily utilized and investigated for the treatment of degenerative retinal conditions, most notably retinitis pigmentosa (RP). The formulation is designed according to TCM principles to tonify the liver and kidney and nourish the blood to improve visual acuity. Clinical research, including trials registered in the Chinese Clinical Trial Registry (e.g., ChiCTR2400086280), focuses on its potential to improve visual function, expand visual fields, and slow the progression of retinal degeneration in patients with RP. As a multi-component herbal product, its therapeutic effects are attributed to a synergistic combination of botanical extracts that may provide neuroprotective and antioxidant support to the photoreceptor cells.
- Brand names
- Peiyuan Mingmu Wan
- Other names
- Peiyuan Mingmu Pill培元明目丸
Beyond the preview
Go deeper on peiyuan mingmu wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on peiyuan mingmu wan.